Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular behavior and gene function.

Bruker shares fell by 2.5%, Illumina by 3.3%, Quanterix by 2.8%, Bio-Techne by 5%, 10X Genomics by 8.8%, and Qiagen by 3.5%. Analysts have noted that this move by the NIH could have a material impact ...

Barclays analyst Luke Sergott lowered the firm’s price target on Bruker to $65 from $69 and keeps an Overweight rating on the shares. The firm ...

Cathie Wood's ARK ETFs have disclosed their daily trades for Monday, February 10th, 2025, with notable transactions across a range of technology and biotech stocks. The largest trade of the day ...

Monday's trading session has revealed notable movements in mega-cap and large-cap stocks, with Alibaba-exch (BABA) and ...